Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H6O4.C5H12N2.Pt |
Molecular Weight | 437.356 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Pt++].[H][C@]1(CN)CCCN1.[O-]C(=O)C2(CCC2)C([O-])=O
InChI
InChIKey=XXUHLUDUCZQMDI-UTYJZAQGSA-L
InChI=1S/C6H8O4.C5H12N2.Pt/c7-4(8)6(5(9)10)2-1-3-6;6-4-5-2-1-3-7-5;/h1-3H2,(H,7,8)(H,9,10);5,7H,1-4,6H2;/q;;+2/p-2/t;5-;/m.1./s1
Molecular Formula | Pt |
Molecular Weight | 195.084 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C5H12N2 |
Molecular Weight | 100.1622 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C6H6O4 |
Molecular Weight | 142.1094 |
Charge | -2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Miboplatin (DWA 2114R) is a platinum analog developed for the treatment of cancer. Miboplatin is an alkylating agent that reached phase III clinical trials in Japan. In spite of its good anticancer activity, the drug did not show any advantage over cisplatin. Further development of this drug for the treatment of breast, ovarian and prostate cancer was discontinued.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:07:08 GMT 2023
by
admin
on
Fri Dec 15 19:07:08 GMT 2023
|
Record UNII |
06241B5S4P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6848
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
C175820
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
DTXSID70908584
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
103775-75-3
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
06241B5S4P
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
SUB08942MIG
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
72031
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
100000081165
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
m830
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | Merck Index | ||
|
36143
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY |